73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Investigating the most allergen-inducing drugs

Investigating the most allergen-inducing drugs

by Scientific Project LomonosovComparison of % of spontaneous reports (SRs) with data on drug-induced anaphylaxis (SRsAs) due to a specific pharmacological group among the total SRsAs structure and %

Investigating the most allergen-inducing drugs

by Scientific Project LomonosovComparison of % of spontaneous reports (SRs) with data on drug-induced anaphylaxis (SRsAs) due to a specific pharmacological group among the total SRsAs structure and %
Study reports progress in long-term protection against ovarian cancer tumors

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or
Two-pronged immunotherapy eliminates metastatic breast cancer in mice

Two-pronged immunotherapy eliminates metastatic breast cancer in mice

by Julia Evangelou Strait,Washington University School of MedicineResearchers at Washington University School of Medicine in St. Louis have identified a way to sensitize metastatic breast cancer

Two-pronged immunotherapy eliminates metastatic breast cancer in mice

by Julia Evangelou Strait,Washington University School of MedicineResearchers at Washington University School of Medicine in St. Louis have identified a way to sensitize metastatic breast cancer
Mathematics supporting fresh theoretical approach in oncology

Mathematics supporting fresh theoretical approach in oncology

byUniversity of the Basque CountryMathematics, histopathology and genomics converge to confirm that highly aggressive clear cell renal cell carcinomas display low levels of intratumour heterogen

Mathematics supporting fresh theoretical approach in oncology

byUniversity of the Basque CountryMathematics, histopathology and genomics converge to confirm that highly aggressive clear cell renal cell carcinomas display low levels of intratumour heterogen
Race, income can determine blood cancer outcomes, studies show

Race, income can determine blood cancer outcomes, studies show

by Ernie MundellIf someone is stricken with a blood cancer or life-threatening clot, they'll probably fare better if they are white and wealthy, three new studies show.The ongoing impact of patien

Race, income can determine blood cancer outcomes, studies show

by Ernie MundellIf someone is stricken with a blood cancer or life-threatening clot, they'll probably fare better if they are white and wealthy, three new studies show.The ongoing impact of patien
For cancer, a biopharmaceutical company and UC San Diego test another kind of immune cell

For cancer, a biopharmaceutical company and UC San Diego test another kind of immune cell

by Bradley J. Fikes, The San Diego Union-TribuneWhen the U.S. Food and Drug Administration approved the first cell-based gene therapies for cancer in 2017, advanced malignancies once seen as terminal

For cancer, a biopharmaceutical company and UC San Diego test another kind of immune cell

by Bradley J. Fikes, The San Diego Union-TribuneWhen the U.S. Food and Drug Administration approved the first cell-based gene therapies for cancer in 2017, advanced malignancies once seen as terminal
Researchers discover compound that fights leukemia and lymphoma

Researchers discover compound that fights leukemia and lymphoma

JANUARY 12, 2024byUniversity of Texas at El PasoRenato Aguilera, Ph.D., a professor in the Department of Biological Sciences at The University of Texas at El Paso, is the principal investigator

Researchers discover compound that fights leukemia and lymphoma

JANUARY 12, 2024byUniversity of Texas at El PasoRenato Aguilera, Ph.D., a professor in the Department of Biological Sciences at The University of Texas at El Paso, is the principal investigator
Scientists develop first bone marrow model that supports human stem cells

Scientists develop first bone marrow model that supports human stem cells

byUniversity of GlasgowSchematic of the bone marrow (BM) niche microenvironment. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-50054-0Scientists have created the first

Scientists develop first bone marrow model that supports human stem cells

byUniversity of GlasgowSchematic of the bone marrow (BM) niche microenvironment. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-50054-0Scientists have created the first
Exploring the biology of 'double positive' T cells

Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou

Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou
Large study finds telehealth is as safe as a visit to the clinic for abortion pills

Large study finds telehealth is as safe as a visit to the clinic for abortion pills

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainA large national study has found that video visits, texting and mailing pills are all effective, as the U.S. Supreme Co

Large study finds telehealth is as safe as a visit to the clinic for abortion pills

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainA large national study has found that video visits, texting and mailing pills are all effective, as the U.S. Supreme Co
First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with